ITMCTR2000003354
Recruiting
Phase 1
Exploratory study for the treatment of rheumatoid arthritis by eliminating dampness
Guangdong Provincial Hospital of Chinese Medicine0 sitesTBD
ConditionsRheumatoid Arthritis
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Rheumatoid Arthritis
- Sponsor
- Guangdong Provincial Hospital of Chinese Medicine
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Research subjects should meet the following diagnostic criteria: ? Western medicine diagnostic criteria: comprehensive judgment using the 2010 ACR / EULAR RA classification standard; ? TCM syndrome types meet the diagnostic criteria of wet syndrome recognized by experts
- •(2\) According to the DAS28\-CRP score, patients whose disease is in a low activity period (2\.6 (3\) The age is 18 \~ 70 years old;
- •(4\) Have not been treated with disease\-modifying antirheumatic drugs (DMARDs), or have previously received DMARDs, but have not used such drugs for at least one month;
- •(5\) A written informed consent form signed by a family member (guardian) with hypertension who agreed to participate in this trial.
Exclusion Criteria
- •Patients who meet or expect to meet any of the following criteria will not be allowed to participate in this study:
- •(1\) history of other autoimmune diseases, such as Sjogren's syndrome and systemic lupus erythematosus; acute or chronic infectious diseases, including hepatitis B or hepatitis C infection; past history of cancer; evidence of active, latent or improperly treated Mycobacterium tuberculosis infection;
- •(2\) Patients with severe cardiovascular, brain, lung, liver, kidney and hematopoietic diseases;
- •(3\) Pregnant women, lactating women or patients with known mental disorders;
- •(4\) Patients with hemoglobin level less than 90 g/L, white blood cell count less than 3\.0 \*10^9/L, or platelet count less than 100 \*10^9/L;
- •(5\) Patients whose glomerular filtration rate is lower than 40 ml/min;
- •(6\) The level of aspartate aminotransferase or alanine aminotransferase was 1\.5 times higher than the upper limit of normal range.
- •(7\) Patients with active gastroduodenal ulcer or gastritis caused by long\-term use of NSAIDs;
- •(8\) Patients allergic to experimental drugs;
- •(9\) Screening patients who participated in other clinical trials within 4 weeks.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Effect of shiva guggulu tablets and kottam chukkadi taila in management of Amavata (one type of joint disorder)Health Condition 1: null- patients suffering from Rheumatoid ArthritisCTRI/2014/04/004531Institute for Post Graduate Teaching and Research in Ayurveda50
Active, not recruiting
Phase 1
REDO study: Research into the effects of lower doses rituximab in patients with rheumatoid arthritisEUCTR2016-002908-15-NLSint Maartenskliniek140
Completed
Not Applicable
Supplemental treatment of rheumatoid arthritis with natural milk antibodies against enteromicrobes and their toxinsJPRN-UMIN000003128Asama Chemical Co. Ltd.,40
Recruiting
Not Applicable
Prospective cohort study of rheumatoid arthritis and Sjogren's syndrome (Prevention against the development of rheumatoid arthritis, through application of musculoskeletal ultrasonography and treatment for periodontal disease, collaboration with Kanazawa, Chiba and Nagasaki UniversityEarly arthritisJPRN-UMIN000014886agasaki University Hospital250
Active, not recruiting
Not Applicable
Effectiveness of Homoeopathic medicine Gaultheria procumbence in the treatment of Rheumatoid arthritisHealth Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvementHealth Condition 2: M059- Rheumatoid arthritis with rheumatoid factor, unspecifiedCTRI/2023/03/050189VINAYAKA MISSION HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITA